Pre-treatment T-cell subsets associate with fingolimod treatment responsiveness in multiple sclerosis

Biomarkers predicting fingolimod (FTY) treatment response in relapsing-remitting multiple sclerosis (RRMS) are lacking. Here, we performed extensive functional immunophenotyping using multiparametric flow cytometry to examine peripheral immune changes under FTY treatment and explore biomarkers of FT...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Sci Rep
Päätekijät: Ghadiri, Mahtab, Rezk, Ayman, Li, Rui, Evans, Ashley, Giacomini, Paul S., Barnett, Michael H., Antel, Jack, Bar-Or, Amit
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6962338/
https://ncbi.nlm.nih.gov/pubmed/31941953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-57114-2
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia